Minimal Residual Disease in Multiple Myeloma

被引：34

作者：

Munshi, Nikhil C. ^{[1
]}

Anderson, Kenneth C. ^{[2
]}

机构：

[1] Harvard Univ, Sch Med, Dana Farber Canc Inst,VA Boston Healthcare Syst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 20期

关键词：

STEM-CELL TRANSPLANTATION; MULTIPARAMETER FLOW-CYTOMETRY; POLYMERASE-CHAIN-REACTION; BONE-MARROW; LENALIDOMIDE; MAINTENANCE; REMISSION; THERAPY; IMPACT;

D O I：

10.1200/JCO.2013.49.2124

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2523 / 2526

页数：4

共 27 条

[1] Oncogenomics to Target Myeloma in the Bone Marrow Microenvironment [J].

Anderson, Kenneth C. .

CLINICAL CANCER RESEARCH, 2011, 17 (06) :1225-1233

[2] Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma [J].

Attal, Michel ;

Lauwers-Cances, Valerie ;

Marit, Gerald ;

Caillot, Denis ;

Moreau, Philippe ;

Facon, Thierry ;

Stoppa, Anne Marie ;

Hulin, Cyrille ;

Benboubker, Lofti ;

Garderet, Laurent ;

Decaux, Olivier ;

Leyvraz, Serge ;

Vekemans, Marie-Christiane ;

Voillat, Laurent ;

Michallet, Mauricette ;

Pegourie, Brigitte ;

Dumontet, Charles ;

Roussel, Murielle ;

Leleu, Xavier ;

Mathiot, Claire ;

Payen, Catherine ;

Avet-Loiseau, Herve ;

Harousseau, Jean-Luc .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19) :1782-1791

[3] Lenalidomide in Myeloma - A High-Maintenance Friend [J].

Badros, Ashraf Z. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19) :1836-1838

[4] F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma [J].

Bartel, Twyla B. ;

Haessler, Jeff ;

Brown, Tracy L. Y. ;

Shaughnessy, John D., Jr. ;

van Rhee, Frits ;

Anaissie, Elias ;

Alpe, Terri ;

Angtuaco, Edgardo ;

Walker, Ronald ;

Epstein, Joshua ;

Crowley, John ;

Barlogie, Bart .

BLOOD, 2009, 114 (10) :2068-2076

[5]

Sarasquete ME, 2005, HAEMATOLOGICA, V90, P1365

[6] Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia [J].

Faham, Malek ;

Zheng, Jianbiao ;

Moorhead, Martin ;

Carlton, Victoria E. H. ;

Stow, Patricia ;

Coustan-Smith, Elaine ;

Pui, Ching-Hon ;

Campana, Dario .

BLOOD, 2012, 120 (26) :5173-5180

[7] Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation [J].

Galimberti, S ;

Benedetti, E ;

Morabito, F ;

Papineschi, F ;

Callea, V ;

Fazzi, R ;

Stelitano, C ;

Andreazzoli, F ;

Guerrini, F ;

Ciabatti, E ;

Martino, M ;

Nobile, F ;

Iacopino, P ;

Petrini, M .

LEUKEMIA RESEARCH, 2005, 29 (08) :961-966

[8]

García-Sanz R, 1999, HAEMATOLOGICA, V84, P328

[9] The Level of Minimal Residual Disease in the Bone Marrow of Patients with Multiple Myeloma before High-Dose Therapy and Autologous Blood Stem Cell Transplantation Is an Independent Predictive Parameter [J].

Korthals, Mark ;

Sehnke, Nina ;

Kronenwett, Ralf ;

Bruns, Ingmar ;

Mau, Jochen ;

Zohren, Fabian ;

Haas, Rainer ;

Kobbe, Guido ;

Fenk, Roland .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (03) :423-431

[10] Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma [J].

Ladetto, M ;

Donovan, JW ;

Harig, S ;

Weller, E ;

Trojan, A ;

Poor, C ;

Schlossman, R ;

Anderson, KC ;

Gribben, JG .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (03) :241-253

← 1 2 3 →